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Summary Adherent cells from carcinomatous pleural effusions of lung cancer patients were tested for their
ability to suppress natural killer (NK) cell activity, and the mechanism involved in the suppression of NK cell
activity was determined. Adherent effusion cells (AEC) were isolated from malignant pleural effusions of
patients by centrifugation discontinuous Ficoll-Hypaque gradients and adherence to serum-coated plastic
dishes, and large granular lymphocytes (LGL) were purified from the peripheral blood of normal individuals
by centrifugation on discontinuous Percoll gradients and further depletion of high-affinity sheep erythrocyte
rosette formation. LGL-mediated lysis of K562 cells was suppressed when LGL were cultured with AEC for
20h, then washed and tested in a 4-h 5'Cr release assay. More profound suppression of NK cell activity was
observed when cytotoxicity was assayed in flat-bottomed wells rather than in round-bottomed wells.
Cytotoxicity assays conducted at the single cell level in agarose revealed that the frequency of LGL binding to
K562 cells and of dead conjugated target cells was reduced after overnight contact with AEC. In agarose
microdroplet assays, functional LGL from normal donors exhibited definitive motility, expressing polarized
shape. In contrast, a small number of LGL with non-polarized configuration migrated from the agarose
droplet after overnight culture with AEC. These results indicate that functionally suppressed NK cells lose
their motility, binding capacity and killing activity, which could be responsible for the suppression of NK cell
activity by AEC.
There is increasing evidence that natural killer
(NK) cells play an important role in host resistance
against tumours, virus-infected cells, and microbes
(Herberman, 1980, 1982). We have quite recently
demonstrated that a minor proportion of human
blood and tumour-associated NK cells kill fresh
autologous tumour cells (Uchida and Micksche,
1983a). Human NK cell activity has been
demonstrated to be exerted by a morphologic
subpopulation of lymphoid cells, termed large
granular lymphocytes (LGL) (Timonen et al., 1981,
1982). The activity of NK cells appears to be highly
regulated in both positive and negative ways
(Herberman, 1980, 1982): Interferon enhances NK
cell activity (Gidlund et al., 1978). Prostaglandins
have both inhibitory and stimulatory effects on NK
cells (Kendal & Targan, 1980). Cell-mediated
suppression of NK cell activity has been well
documented in physiological, pathological, and
experimental conditions of mice expressing defective
or normal NK cell activity (Savary & Lotzova,
1978; Cudkowicz & Hochman, 1979; Santoni et al.,
1980; Gerson et al., 1981). Both adherent and non-
adherent suppressor cells have been shown to be
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involved in the depression of NK cell activity of
these animal models. In humans, little is known
about down-regulation of NK cell activity by
suppressor cells (Allavena et al., 1981; Bordignon et
al., 1982). We have recently reported that human
NK cell activity is suppressed by adherent cells
from carcinomatous pleural effusions of cancer
patients (Uchida & Micksche, 1981a, 1982a, 1983b)
and from the peripheral blood of postoperative
cancer patients (Uchida et al., 1982; Uchida &
Micksche, 1982b). In these studies adherent
suppressor cells have been shown not to inhibit
directly the effector phase of NK cell-mediated lysis
of target cells but to suppress the maintenance of
functional NK cells and the interferon-induced
development of NK cells independently of
prostaglandin induction (Uchida & Micksche,
1981a, 1982a, 1983b).
NK cell activity has usually been tested in short-
term 51Cr-release assays. The single cell cytotoxicity
assay in agarose has recently been introduced to
evaluate the binding capacity and lytic function of
NK cells at the single cell level (Grimm &
Bonavida, 1979; Timonen et al., 1982). NK cells
have been shown to be highly motile cells (Saksela
& Timonen, 1980; Muse & Koren, 1982). Neither
"1Cr-release assays nor single cell level assays,
however, are capable of detecting the first step of
NK cell-mediated lysis of target cells viz motility of
NK cells. To determine directly the motility of NK
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cells, we have modified the agarose microdroplet
assay which was originally developed as a
migration inhibition assay (Tagliabue et al., 1978).
In the present study the mechanism responsible for
the suppression of NK cell activity by adherent
cells from malignant pleural effusions of cancer
patients has been analysed by using 51Cr-release
assays in round-bottomed and flat-bottomed wells,
single cells assays in agarose, and agarose micro-
droplet assays.
Materials and methods
Adherent effusion cells (AEC)
AEC were isolated from carcinomatous pleural
effusions of 6 patients with lung carcinoma, as
described in detail elsewhere (Uchida & Micksche,
1981a, b, 1983a). Specimens of pleural effusions
were centrifuged at 400g for 5min. Cells were
washed, suspended at a concentration of 106ml- 'in
RPMI-1640 supplemented with 25mM HEPES,
2mM L-glutamine 100U penicillin ml-1, 100 ig
streptomycinml-1, and 10% heat-inactivated foetal
calf serum (Gibco Bio-Cult, Glasgow, Scotland)
(complete medium), and layered on discontinuous
gradients of 75% and 100% Ficoll-Hypaque. After
centrifugation at 400g for 30min, mononuclear
cells were collected from the 100% interface,
tumour cells and mesothelial cells from the 75%
interface, and erythrocytes, polymorphonuclear cells
and aggregated tumour cells from the bottom. The
procedure was repeated if separation was not
successful as judged by morphology. Mononuclear
cells having <5% contamination with tumour cells
as judged by morphologic examination of Wright-
Giemsa-stained smears were accepted for use. The
mononuclear cells were then incubated for 1h at
37°C in plastic dishes that had been precoated with
foetal calf serum. After incubation, non-adherent
cells were removed, and the dish was washed with
cold medium. Adherent cells were harvested from
the dish after 15min incubation with Versene
(1/5000, Gibco Bio-Cult) and by vigorous washing
with a pipette, then washed and suspended in
complete medium. The adherent cells contained
>95% monocyte/macrophages as judged by
morphologic examination and nonspecific esterase
staining.
Large granular lymphocytes (LGL)
LGL were prepared according to the method of
Timonen et al. (1981, 1982), as described previously
(Uchida & Micksche, 1981b, 1983a). Mononuclear
cells were isolated from heparinized peripheral
blood of normal donors by centrifugation on
Ficoll-Hypaque gradients and suspended in
complete medium. The mononuclear cells were
incubated for 1 h at 37°C in plastic dishes, then
passed through Sephadex GlO columns, further
incubated for 1 h at 37°C in nylon wool columns,
and eluted with warm complete medium.
Nonadherent cells (5 x 107) were placed on the top
of 7-step discontinuous gradients of 40-55% Percoll
(Pharmacia Fine Chemicals, Uppsala, Sweden) in
medium by 2.5% increment in 15-ml plastic tubes,
and the tube was centrifuged at 550g for 30min.
The cells collected from the low density fractions 2
and 3 were pooled and further purified by depletion
of high-affinity sheep erythrocyte rosette forming
cells at 29°C on Ficoll-Hypaque gradients. The
LGL-enriched fraction usually contained >90%
LGL as judged by morphologic examination of
Giemsa-stained cytocentrifuged smears (hereafter
refered to as LGL).
NK suppressor cell assay
LGL (106ml-1) in complete medium were
precultured alone or with a half the number of
AEC, as described in detail elsewhere (Uchida &
Micksche, 1981a, 1982a, 1983a). After 20h of
culture the cells were harvested, washed and
suspended in complete medium. Since the presence
of AEC in a 4h cytotoxicity assay was not required
for suppression of NK cell activity by AEC
(Uchida & Micksche, 1981a, 1982a), the harvested
cells were depleted of AEC on Sephadex GIO
columns. There were no differences in the recovery
and purity of viable LGL cultured alone and with
AEC.
51Cr-release cytotoxicity assay
A 4h "Cr-release assay was done using the K562
human erythroleukemia cell line as targets, as
described in detail elsewhere (Uchida & Micksche,
1981a, b, 1983; Uchida et al., 1982). Briefly, lOOdI
51Cr-labelled target cells (5 x 103) and 100pl LGL
(at different numbers) were added to each round-
or flat-bottomed well of microtiter plates. After 4h
incubation the supernatant was collected, and the
specific 51Cr-release in percentage cytotoxicity was
calculated by the formula for triplicate samples:
%Cytotoxicity =
test cpm - spontaneous cpm
maximum cpm - spontaneous cpm 100
Agarose single cell cytoxicity assay
This assay was performed according to the method
of Grimm & Bonavida (1979) with a minor
modification as described previously (Uchida &NK SUPPRESSION BY ADHERENT CELLS 19
Micksche, 1983a). Equal numbers (2 x 105) of LGL
and K562 were mixed in 0.2ml medium in small
plastic tubes, incubated for 10min at 37°C, and
centrifuged at lOOg for 5min, followed by gentle
suspension with a pipette. One per cent agarose
(0.5ml; Marine Colloides, Rockland, Me, USA),
which had been kept in the liquid phase at 37°C
was added to the conjugate suspension. One
hundredyl of the agarose-conjugate mixture were
transfered on to agar-precoated microscope slides.
After the solidification of agarose, the slide was
placed in plastic dishes, filled with warm medium
and incubated for 4h at 37°C. After incubation the
slide was stained with 0.2% trypan blue and fixed
with 1% formaldehyde. The percentage of LGL
forming conjugates with K562 was determined by
counting 200 LGL, and that of dead conjugated
target cells was scored by counting 100 conjugates.
Spontaneous target cell death was assessed by
counting 200 target cells in samples in the absence
of effector cells and did not exceed 5%. The
percentage of active killer cells was calculated by
the formula:
%Active killer cells
= % target binding cells
x % dead conjugated target cells
x (1- % spontaneous target death).
Agarose microdroplet assay
A modification of the agarose microdroplet assay
of Tagliabue et al. (1978) was used for the detection
of the motility of NK cells. LGL suspension was
centrifuged at 200g for 5min, and the supernatant
was removed. The cell pellet was briefly incubated
at 37°C and suspended in 0.2% agarose (Marine
Colloids) at a concentration of 108ml-1 by gentle
agitation. A 2yl droplet of agarose-cell mixture
(2 x 105 cells) was placed in the centre of each well
of migration plates (Sterilin, Teddington, GB) with
a microdispenser (Hamilton, Alexandria, Va, USA).
Each droplet was allowed to solidify at room
temperature for 8min. Each well was then filled
with complete medium and covered with a cover
glass. The plate was incubated for 4h at 370C in a
humidified 5% CO2 atmosphere. After incubation
the number of cells migrating from the agarose
droplet to surrounding medium was scored under
Wild 40 inverted microscope. Data are expressed as
the mean of quadruplicate samples.
Results
Suppression ofNK cell activity in Cr-release assay
LGL from the peripheral blood of normal donors
were precultured for 20h alone or with half the
number of AEC of cancer patients, then washed,
depleted of AEC, and tested for cytotoxicity against
K562 in a 4h 5"Cr-release assay. Lysis of K562 by
LGL was suppressed by AEC after overnight
contact (Table T). The mere addition of AEC to a
4h cytotoxicity assay resulted in no inhibition of
NK cell activity (data not shown), as previously
described (Uchida & Micksche, 1981a, 1982a). The
degree of suppression of NK cell activity by AEC
was higher when cytotoxicity was assayed in flat-
bottomed wells rather than in round-bottomed
wells. The recovery of viable LGL cultured with
AEC was comparable to that cultured alone (data
not shown). These results suggest that the
suppression of NK cell activity of LGL by AEC is
not due to a loss of NK cells but to a dysfunction
of NK cells caused after 20h contact with AEC.
Suppression ofbinding and killing ofNK cells in the
single cell assay
To examine the effects of AEC on binding capacity
and killing activity of NK cells, cytotoxicity against
K562 was determined in a single cell cytotoxicity
assay in agarose. The number of LGL forming
conjugates with K562 was reduced when LGL were
precultured with AEC (Table II). In addition, the
frequency of dead conjugated target cells among
LGL-K562 conjugates was lower in LGL cultured
with AEC than in LGL cultured alone Thus, the
number of active killer cells was estimated to be
markedly decreased after 20h contact between LGL
and AEC. There were no differences in the numbers
of target binding cells, dead conjugated target cells
and active killer cells between fresh LGL and 20h
cultured LGL (data not shown). These results
indicate that both binding capacity and lytic
activity of NK cells are suppressed by AEC after
overnight contact.
Suppression ofmotility in agarose microdroplet assay
To ascertain whether the motility of NK cells is
affected by AEC, the motility of LGL was
determined using an agarose microdroplet assay.
Functional LGL from normal individuals migrated
vigorously from an agarose droplet to surrounding
medium (Figure 1, Table III), indicating that NK
cells have a strong motility. However, after
overnight incubation with AEC, only a small
number of LGL migrated from the droplet.
Furthermore, functional LGL expressed a polarized
morphology, whereas suppressed LGL were round
and less motile (Figure 1). No differences were
observed in the motility of fresh LGL and 20h
cultured LGL (data not shown). These data
indicate that NK cells lose their strong motility
when NK cells are cultured with AEC for 20h.20 A. UCHIDA et al.
Table I Suppression of NK activity determined in 5'Cr-release assays
% Cytotoxicity (% suppression)
Round-well assay
Exp. AEC added 2.5:1 5:1
Flat-well assay
2.5:1
1 None 49.5 67.2
AEC added 25.3a(49) 32.4a(52)
2 None 27.4 41.0
AEC added 10.3a(58) 14.1a(66)
3 None 50.7 71.3
AEC added 33.5a(34) 46.3(35)
4 None 22.2 33.1
AEC added 7.7a(65) 10.8a(67)
5 None
AEC added
6 None
AEC added
12.7
4.1a(68)
39.9
20.4a(49)
20.8
5.Oa(76)
55.9
30.8a(45)
34.7 49.6
10.2a(71) 13.9a(72)
23.3 33.3
5.6a(76) 7.9a(76)
39.7 56.1
19.4a(51) 30.3a(46)
21.5 25.4
4.3a(80) 5.1a(80)
12.8 20.0
1.8a(86) 4.0a(80)
32.6 48.4
12.2a(63) 20.3a(58)
LGL were cultured for 20h alone or with half the number of QEC, then
washed, passed through Sephadex GIO columns and tested for cytotoxicity against
K562 either in round-bottomed wells or in flat-bottomed wells. Results are
expressed as the mean of triplicate samples at effector to target cell ratios of 2.5:1
and 5:1.
aValue is significantly lower than that cultured alone by Student's t-test as
P<0.05.
Table II Suppression of binding and killing activity of NK cells
determined in single cell assays
% Target % Dead % Active
binding conjugated killer
cells target cells cells
Exp. AEC added (% suppression) (% suppression) (% suppression)
1 None 38+3 54+2 19.9+1.6
AEC added 12+2a(68) 40+2a(26) 4.7+0.6a(76)
2 None 31+4 45+2 13.3+1.2
AEC added 12+2a(61) 31 +4a(31) 3.6+0.7a(73)
3 None 57+3 51+4 17.6+2.1
AEC added 39+2a(32) 38+2a(25) 14.1+0.7a(49)
4 None 33+2 43+4 13.6+1.3
AEC added 15+2a(55) 21 +1(51) 3.0±0.4a(78)
5 None 20+1 36+4 7.0+0.8
AEC added 18+1 (10) 7+3a(81) 1.2+0.5a(83)
6 None 40+3 48+4 18.2+1.5
AEC added 24+3a(40) 31+4a(35) 7.1+0.9a(61)
LGL of normal donors were cultured alone or with AEC for 20h, then
washed, passed through Sephadex GIO columns, and tested for cytotoxicity
against K562 cells in a 4h single cell cytotoxicity assay in agarose. Results
are expressed as the mean+s.e. of 3 determinants.
aValue is significantly lower than that cultured alone by Student's t-test
as P<0.05.
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Figure 1 LGL of a normal donor were cultured for 20h alone (A) or with half the number of AEC of a
cancer patient (B), washed, passed through Sephadex GIO columns and tested for motility in an agarose
microdroplet assay (x 130).
Table III Suppression of motility of NK cells determined
in agarose microdroplet assay
Number ofcells migrated
Exp. LGL LGL+AEC % Suppression
1 1,000+85 372+32a 65
2 744+53 332+ 19a 55
3 1,800+98 1,340+72a 28
4 664+56 381 +32a 43
5 317+ 12 277+ 8a 13
6 932+42 728+45a 22
LGL were cultured alone or with AEC for 20h, then
washed, depleted of AEC on Sephadex GIO columns and
tested for motility in a 4h agarose microdroplet assay.
Results are expressed as the mean+s.e. of quadruplicate
samples.
aValue is significantly lower than that of LGL by
Student's t-test at P<0.05.
Discussion
In the present report several observations have been
made concerning the mechanism of suppression of
NK cell activity by adherent effusion cells and the
use of the agarose microdroplet assay in the
assessment of the motility of NK cells. In
agreement with our previous observations (Uchida
& Micksche, 1981a, 1982a, 1983b), adherent cells
from carcinomatous pleural effusions of cancer
patients, but not of normal healthy donors, were
found to be potent inhibitors of the expression of
NK cell activity. In the previous studies we have
demonstrated that AEC do not directly inhibit the
effector phase of NK cell-mediated lysis of tumour
target cells but do suppress the maintenance of
functional NK cells and interferon-induced
augmentation of NK cell activity independently of
prostaglandin induction (Uchida & Micksche,
1981a, 1982a). Similarly, tumour-associated
lymphoid cells from ascitic ovarian carcinoma of
patients and bronchoalveolar macrophages from
normal individuals have been shown to inhibit NK
cell activity (Allavena et al., 1981; Bordignon et al.,
1982). In these studies, however, the mechanism by
which suppressor cells inhibit NK cell activity was
not clarified.
It has recently been suggested that NK cells
recycle and lyse more than one target cell in a 4h
cytotoxicity assay (Ullberg & Jondal, 1981). In the
present study 4h 51Cr-release assays were
performed both in round-bottomed wells and flat-
bottomed wells. The higher degree of suppression
of NK cell activity was observed in flat-bottomed
well assays than in round-bottomed well assays
(Table I). As the cell density was lower in flat-22 A. UCHIDA et al.
bottomed wells than in round-bottomed wells, our
findings may indicate that the motility of NK cells
is suppressed by AEC. The agarose microdroplet
assay has indeed provided evidence indicating that
NK cells lose their strong motility after overnight
contact with AEC. These data are consistent with
the findings obtained in 51Cr-release cytotoxicity
assays which clearly demonstrated depressed lysis of
K562 cells (Table I, Uchida & Micksche, 1981a,
1982a, 1983b). Collectively, it seems likely that the
recycling capacity of NK cells is down-regulated by
AEC, although the simultaneous calculation of
recycling capacity by the formula of Ullberg &
Jondal (1981) may be necessary to draw the
conclusion. In contrast, AEC of patients with
nonmalignant disorders are found not to inhibit
NK cell activity when determined in 51Cr-release
assays and agarose microdroplet assays (data not
shown), suggesting that the suppression of NK cell
activity by AEC is a function of the malignant
state.
A microcinematographic analysis of the agarose
microdroplet assay has revealed that only polarized
LGL can move toward tumour target cells present
in the surrounding medium, form conjugates with
the target cells and finally kill them (manuscript in
preparation). LGL have recently been demonstrated
to exhibit a polarized morphology and to be highly
motile cells (Muse & Koren, 1982; Saksela &
Timonen, 1980). The impairment of polarization of
LGL after overnight contact with AEC as described
in this paper could be one of the mechanisms
responsible for the suppression of NK cell activity
by AEC. The inhibition of binding capacity of NK
cells by AEC has been observed in the single cell
cytotoxicity assay in agarose (Table II). A previous
study has demonstrated that actin-containing
microfilaments play an important role in the
movement and conjugate formation of cells since
cytochalasin B inhibits these functions (Carpen et
al., 1981). Our preliminary studies have revealed
that cytochalasin B inhibits the motility of NK cells
in agarose microdroplet assays and the binding
capacity of NK cells in single cell level assays.
Taken together, it seems possible that micro-
filaments of NK cells are disrupted by AEC after
overnight contact.
Our studies using the single cell level assay has
also demonstrated that the lethal hit of NK cells is
suppressed when NK cells are precultured with
AEC for 20h. The postbinding lytic events have
been reported to consist of several different steps
(Hiserodt et al., 1982). The stage of the lytic
process suppressed by AEC still needs to be
delineated.
It seems unlikely that AEC suppress NK cell
activity through induction of prostaglandins and
oxidative bursts, since prostaglandins and oxidative
bursts inhibit the effector phase of NK cells,
whereas the AEC of cancer patients suppress the
maintenance of functional NK cells and IFN-
induced development of active NK cells (Uchida &
Micksche, 1981a, 1982a, b, 1983b). Furthermore,
prostaglandins are found not to inhibit the motility
of NK cells in agarose microdroplet assays (data
not shown).
Suppression of NK cell activity seems to be a
complex phenomenon resulting from a multitude of
factors. Our studies strongly suggest that adherent
effusion cells of lung cancer patients suppress the
NK cell activity by inhibiting the motility, binding
capacity and lethal hit of NK cells after 20h
contact with NK cells. Similar regulatory
mechanisms could be operative in vivo, since our
preliminary studies have revealed that LGL from
malignant pleural effusions of cancer patients
expressed impaired motility, binding capacity and
lytic function.
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